A trial funded by Nestle has found that infant formula enriched with milk-derived oligosaccharides (MOS), a prebiotic, has helped to improve gut microbiota in babies, such as increasing the abundance of Bifidobacterium.
You May Also Like

Global conference on infant nutrition in Wellington
INCOctober 17, 2022

US formula shortage: FDA refutes claims of postponing all applications under discretion policy
INCAugust 30, 2022

‘Possible opportunity’: ANZ infant nutrition firms gear up for US market entry amid formula shortage
INCJune 27, 2022